Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Johnson

Showing results (281-290 of 312) with videos related to

Pageof 32
Sort By:
Gastrointestinal Endoscopy|May 1, 2007
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer RoundtableDavid Lieberman, Marion Nadel, Robert A Smith, et al.
Plos One|October 22, 2016
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Plos One|January 5, 2019
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Journal of General Internal Medicine|February 18, 2016
Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control TrialSusan P Bell, Jeffrey L Schnipper, Kathryn Goggins, et al.
Journal of the American College of Radiology : JACR|April 7, 2007
Quality improvement in radiology: white paper report of the Sun Valley Group meetingC Daniel Johnson, Stephen J Swensen, Kimberley E Applegate, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
Gastroenterology|April 4, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 7, 2022
Imaging Review of Gastrointestinal Motility DisordersAvinash K Nehra, Shannon P Sheedy, C Daniel Johnson, et al.
Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.
Pageof 32

Showing results (281-290 of 312) with videos related to

Sort By:
Pageof 32
Gastrointestinal Endoscopy|May 1, 2007
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer RoundtableDavid Lieberman, Marion Nadel, Robert A Smith, et al.
Plos One|October 22, 2016
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Plos One|January 5, 2019
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical StudyPirow Bekker, Daniel Dairaghi, Lisa Seitz, et al.
Journal of General Internal Medicine|February 18, 2016
Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control TrialSusan P Bell, Jeffrey L Schnipper, Kathryn Goggins, et al.
Journal of the American College of Radiology : JACR|April 7, 2007
Quality improvement in radiology: white paper report of the Sun Valley Group meetingC Daniel Johnson, Stephen J Swensen, Kimberley E Applegate, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
Gastroenterology|April 4, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 7, 2022
Imaging Review of Gastrointestinal Motility DisordersAvinash K Nehra, Shannon P Sheedy, C Daniel Johnson, et al.
Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.
Pageof 32